日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma.

载药吲哚菁绿 J 聚集体激活金属免疫疗法,用于持续光热疗法治疗肝细胞癌

He Kaiming, Chen Desheng, Zhu Dongzi, Zheng Wenjie, Lyu Lei, Zhang Mingshen, Chen Zeping, Wang Xiaowen, Hu Yongwei, Fu Binsheng

Case Report: Split liver transplantation for graft liver failure due to antibody-mediated rejection after immune checkpoint inhibitor therapy

病例报告:免疫检查点抑制剂治疗后因抗体介导的排斥反应导致移植肝功能衰竭,行劈裂式肝移植

Tang, Hui; Fu, Binsheng; Yang, Qing; Yao, Jia; Zeng, Kaining; Feng, Xiao; Yang, Yang; Yi, Shuhong

Identification of tumor immune infiltration-associated VPS72 and prognostic significance of VPS72 and CD8A in hepatocellular carcinoma.

肿瘤免疫浸润相关VPS72的鉴定及VPS72和CD8A在肝细胞癌中的预后意义

Yang Zhou, Feng Xiao, Yu Haoyuan, Lv Lei, Gao Chengli, Liu Wei, Yi Shuhong, Jia Changchang, Fu Binsheng

An 82-year-old recipient of split liver transplantation worldwide: A case report

全球范围内,一名82岁接受劈裂式肝移植的患者:病例报告

Feng, Xiao; Fu, Binsheng; Yang, Qing; Zeng, Kaining; Yi, Huimin; Yi, Shuhong; Yang, Yang

Chinese clinical practice guidelines for pediatric split liver transplantation

中国儿童劈裂式肝移植临床实践指南

Fu, Binsheng; Feng, Xiao; Liu, Jianrong; Ren, Jie; Wang, Jin; Yi, Shuhong; Yang, Yang

Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

撤稿声明:LINC01234/MicroRNA-31-5p/MAGEA3轴介导肝细胞癌细胞的增殖和化疗耐药性

Chen, Yunhao; Zhao, Hui; Li, Haibo; Feng, Xiao; Tang, Hui; Qiu, Chunhui; Zhang, Jianwen; Fu, Binsheng

Thermal ablation as an alternative to liver transplantation for hepatocellular carcinoma with clinically significant portal hypertension: propensity score matching study

热消融术作为肝移植替代疗法治疗伴有临床显著门静脉高压的肝细胞癌:倾向评分匹配研究

Long, Yinglin; Yang, Zhou; Zeng, Qingjing; Liu, Zhongqi; Xu, Erjiao; He, Xuqi; Yuan, Lianxiong; Fu, Binsheng; Li, Kai

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation

替诺福韦与恩替卡韦在降低肝移植后乙型肝炎病毒相关肝细胞癌复发风险方面的比较

Yang, Jianming; Chen, Yewu; Sun, Haobin; Zhang, Xijian; Wang, Jianfeng; Liang, Zhixing; Fu, Binsheng; Zhang, Tong; Yi, Shuhong; Deng, Yinan; Yang, Yang

A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase I/II randomized, open-label, controlled trial

一种基于间充质干细胞的新型免疫诱导策略用于ABO血型不相容肝移植:一项I/II期随机、开放标签、对照试验

Zhang, Yingcai; Zhang, Jiebin; Yi, Huimin; Zheng, Jun; Cai, Jianye; Chen, Wenjie; Lu, Tongyu; Chen, Liang; Du, Cong; Liu, Jianrong; Yao, Jia; Zhao, Hui; Wang, Guoying; Fu, Binsheng; Zhang, Tong; Zhang, Jian; Wang, Genshu; Li, Hua; Xiang, Andy Peng; Chen, Guihua; Yi, Shuhong; Zhang, Qi; Yang, Yang

Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion

环状RNA circ-102,166作为miR-182和miR-184的分子海绵,抑制肝细胞癌的增殖和侵袭。

Li, Rong; Deng, Yinan; Liang, Jinliang; Hu, Zhongying; Li, Xuejiao; Liu, Huanyi; Wang, Guoying; Fu, Binsheng; Zhang, Tong; Zhang, Qi; Yang, Yang; Chen, Guihua; Liu, Wei